202 related articles for article (PubMed ID: 3273886)
1. Severe daytime somnolence in patients treated with an MAOI.
Teicher MH; Cohen BM; Baldessarini RJ; Cole JO
Am J Psychiatry; 1988 Dec; 145(12):1552-6. PubMed ID: 3273886
[TBL] [Abstract][Full Text] [Related]
2. [Abuse of the monoamine oxidase (MAOI) inhibitors as antidepressive drugs: a critical review].
García-Campayo JJ; Sanz-Carrillo C; Ferrández Payo M
Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1995; 23(4):217-22. PubMed ID: 7484306
[TBL] [Abstract][Full Text] [Related]
3. Two cases of hypomania following the addition of L-tryptophan to a monoamine oxidase inhibitor.
Goff DC
Am J Psychiatry; 1985 Dec; 142(12):1487-8. PubMed ID: 4073318
[TBL] [Abstract][Full Text] [Related]
4. [Classical monoamine oxidase inhibitor: not registered for, but still a place in the treatment of depression].
Nolen WA
Ned Tijdschr Geneeskd; 2003 Oct; 147(40):1940-3. PubMed ID: 14574774
[TBL] [Abstract][Full Text] [Related]
5. Refractory depression treated with high doses of monoamine oxidase inhibitor.
Guze BH; Baxter LR; Rego J
J Clin Psychiatry; 1987 Jan; 48(1):31-2. PubMed ID: 3804984
[TBL] [Abstract][Full Text] [Related]
6. Switching monoamine oxidase inhibitors.
True BL; Alexander B; Carter B
Drug Intell Clin Pharm; 1985 Nov; 19(11):825-7. PubMed ID: 4064915
[TBL] [Abstract][Full Text] [Related]
7. Adverse consequences of fluoxetine-MAOI combination therapy.
Feighner JP; Boyer WF; Tyler DL; Neborsky RJ
J Clin Psychiatry; 1990 Jun; 51(6):222-5. PubMed ID: 2347858
[TBL] [Abstract][Full Text] [Related]
8. Acute cardiovascular response to monoamine oxidase inhibitors: a prospective assessment.
Keck PE; Vuckovic A; Pope HG; Nierenberg AA; Gribble GW; White K
J Clin Psychopharmacol; 1989 Jun; 9(3):203-6. PubMed ID: 2738182
[TBL] [Abstract][Full Text] [Related]
9. Continuation and maintenance treatments in major depression: the neglected role of monoamine oxidase inhibitors.
Kennedy SH
J Psychiatry Neurosci; 1997 Mar; 22(2):127-31. PubMed ID: 9074307
[TBL] [Abstract][Full Text] [Related]
10. Possible monoamine oxidase inhibitor-serotonin uptake inhibitor interaction: fluoxetine clinical data and preclinical findings.
Beasley CM; Masica DN; Heiligenstein JH; Wheadon DE; Zerbe RL
J Clin Psychopharmacol; 1993 Oct; 13(5):312-20. PubMed ID: 8227489
[TBL] [Abstract][Full Text] [Related]
11. MAOIs in the contemporary treatment of depression.
Thase ME; Trivedi MH; Rush AJ
Neuropsychopharmacology; 1995 May; 12(3):185-219. PubMed ID: 7612154
[TBL] [Abstract][Full Text] [Related]
12. [Elderly patients, classical monoamine oxidase inhibitors and intercurrent somatic diseases].
Oostervink F; Bouvy PF; Touw DJ
Ned Tijdschr Geneeskd; 2003 Oct; 147(40):1937-40. PubMed ID: 14574773
[TBL] [Abstract][Full Text] [Related]
13. Common side effects associated with monoamine oxidase inhibitors.
Remick RA; Froese C; Keller FD
Prog Neuropsychopharmacol Biol Psychiatry; 1989; 13(3-4):497-504. PubMed ID: 2748873
[TBL] [Abstract][Full Text] [Related]
14. Adverse reactions to monoamine oxidase inhibitors. Part I. A comparative study.
Rabkin J; Quitkin F; Harrison W; Tricamo E; McGrath P
J Clin Psychopharmacol; 1984 Oct; 4(5):270-8. PubMed ID: 6386898
[TBL] [Abstract][Full Text] [Related]
15. Combining stimulants with monoamine oxidase inhibitors: a review of uses and one possible additional indication.
Feinberg SS
J Clin Psychiatry; 2004 Nov; 65(11):1520-4. PubMed ID: 15554766
[TBL] [Abstract][Full Text] [Related]
16. Toxic reactions to the combination of monoamine oxidase inhibitors and tryptophan.
Pope HG; Jonas JM; Hudson JI; Kafka MP
Am J Psychiatry; 1985 Apr; 142(4):491-2. PubMed ID: 3976924
[TBL] [Abstract][Full Text] [Related]
17. Combining tricyclic and monoamine oxidase inhibitor antidepressants.
Spiker DG; Pugh DD
Arch Gen Psychiatry; 1976 Jul; 33(7):828-30. PubMed ID: 942286
[TBL] [Abstract][Full Text] [Related]
18. Addition of monoamine oxidase inhibitors to carbamazepine: preliminary evidence of safety and antidepressant efficacy in treatment-resistant depression.
Ketter TA; Post RM; Parekh PI; Worthington K
J Clin Psychiatry; 1995 Oct; 56(10):471-5. PubMed ID: 7559374
[TBL] [Abstract][Full Text] [Related]
19. Monoamine oxidase inhibitors in resistant major depression. A double-blind comparison of brofaromine and tranylcypromine in patients resistant to tricyclic antidepressants.
Nolen WA; Haffmans PM; Bouvy PF; Duivenvoorden HJ
J Affect Disord; 1993 Jul; 28(3):189-97. PubMed ID: 8408980
[TBL] [Abstract][Full Text] [Related]
20. Quetiapine for insomnia associated with refractory depression exacerbated by phenelzine.
Sokolski KN; Brown BJ
Ann Pharmacother; 2006 Mar; 40(3):567-70. PubMed ID: 16478812
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
